marijuana stocks news

Form 8-K for LEXARIA CORP.


20-Jan-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing Lexaria test results on nitric oxide filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.Exhibit No. Description

99.1 News Release dated January 20, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tetra Bio-Pharma Inc. (TBPMF) Engages Dalton Pharma for GMP Manufacturing of ARDS-003

Tetra Bio-Pharma Engages Dalton Pharma for GMP Manufacturing of ARDS-003 Tetra Bio-Pharma…

 Neptune Wellness Solutions Inc. (NEPT) Obtains Sales License by Health Canada

Neptune Obtains Sales License by Health Canada  Neptune Wellness Solutions Inc. (“Neptune”…

Ascend Wellness Holdings, Inc. (AAWH) Expands Reach in Pennsylvania with Third Dispensary

AWH Expands Reach in Pennsylvania with Third Dispensary Ascend Wellness Holdings, Inc.…

Curaleaf Holdings, Inc. (CURLF) New Branding for Illinois Retail Locations

Curaleaf Announces New Branding for Illinois Retail Locations, Opening of New Westmont…